| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |